Cite
HARVARD Citation
Moll, J. et al. (2019). A bypass mechanism of abiraterone‐resistant prostate cancer: Accumulating CYP17A1 substrates activate androgen receptor signaling. Prostate. 79 (9), pp. 937-948. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Moll, J. et al. (2019). A bypass mechanism of abiraterone‐resistant prostate cancer: Accumulating CYP17A1 substrates activate androgen receptor signaling. Prostate. 79 (9), pp. 937-948. [Online].